Download PDFPDF
Urological management of acute epididymo-orchitis in sexually active young men: too great a public health risk?
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re: Urological Management of Epididymo-Orchitis; Simple, Ofloxacin for all!
    • Colm O`Mahony, Consultant in Sexual Health
    • Other Contributors:
      • John Evans-Jones, Specialist Registrar

    The letter by Philips et al1 about urological management of acute epididymo-orchitis reflects the experience of all of us who pick up the pieces after mis-management of epididymo-orchitis. However, before we can criticise our Urology colleagues we really have to look at our guidelines and see how useful they are? The BASHH Guideline for Management of Epididymo-Orchitis2 is largely aimed at level 3 services that have ins...

    Show More
    Conflict of Interest:
    None declared.